SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 308 filers reported holding SHOCKWAVE MED INC in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,368,878 | -15.0% | 1,398,136 | +21.8% | 0.47% | -10.4% |
| Q2 2023 | $327,589,031 | +42.9% | 1,147,784 | +8.5% | 0.53% | +39.8% |
| Q1 2023 | $229,291,220 | +67.0% | 1,057,470 | +58.3% | 0.38% | +55.1% |
| Q4 2022 | $137,313,349 | -25.6% | 667,834 | +0.6% | 0.24% | -25.0% |
| Q3 2022 | $184,562,000 | +38.4% | 663,726 | -4.8% | 0.32% | +44.0% |
| Q2 2022 | $133,330,000 | -16.2% | 697,443 | -9.1% | 0.22% | +7.1% |
| Q1 2022 | $159,018,000 | +22.5% | 766,870 | +5.4% | 0.21% | +36.4% |
| Q4 2021 | $129,772,000 | -24.8% | 727,707 | -13.2% | 0.15% | -27.0% |
| Q3 2021 | $172,671,000 | +4.6% | 838,699 | -3.6% | 0.21% | +7.1% |
| Q2 2021 | $165,004,000 | +45.5% | 869,677 | -0.1% | 0.20% | +37.8% |
| Q1 2021 | $113,441,000 | +40.4% | 870,878 | +11.8% | 0.14% | +45.9% |
| Q4 2020 | $80,803,000 | +124.9% | 779,045 | +64.4% | 0.10% | +92.2% |
| Q3 2020 | $35,925,000 | +259.5% | 473,951 | +124.7% | 0.05% | +218.8% |
| Q2 2020 | $9,992,000 | – | 210,940 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |